Zydus Lifesciences Company Description

Zydus Lifesciences Limited engages in the research, development, production, marketing, distribution, and sale of pharmaceutical products in India, the United States, and internationally.

It operates through two segments: Pharmaceuticals and Consumer Products. It offers finished dosage human formulations, such as generics; branded generics; specialty formulations, including biosimilars and vaccines; active pharmaceutical ingredients; consumer wellness products; animal healthcare products; and products in the therapeutic areas of pain management, neurology, metabolic disorder, and liver diseases.

The company provides the products under the Everyuth, Nutralite, SugarFree, Complan, Glucon-D, and Nycil brands.

In addition, the company offers a pipeline of biological products in the areas of oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology, and infectious illnesses.

Further, it engages in the investment, animal health and veterinary, pharmacy retail, and manpower supply and administration activities.

The company was formerly known as Cadila Healthcare Limited and changed its name to Zydus Lifesciences Limited in February 2022.

Zydus Lifesciences Limited was founded in 1952 and is headquartered in Ahmedabad, India. Zydus Lifesciences Limited is a subsidiary of Zydus Family Trust.

Zydus Lifesciences Limited

Country	India
Founded	1952
Industry	Pharmaceutical Preparations
Employees	26,921
CEO	Sharvil Patel

Contact Details

Address: Zydus Corporate Park Ahmedabad, 382481 India
Phone	91 79 4804 0000
Website	zyduslife.com

Stock Details

Ticker Symbol	532321
Exchange	Bombay Stock Exchange
Fiscal Year	April - March
Reporting Currency	INR
SIC Code	2834

Key Executives

Name	Position
Sharvil Patel	Chief Executive Officer
Nitinkumar Parekh	Chief Financial Officer
Ganesh Nayak	Chief Operating Officer
Arvind Bothra	Head of Investor Relations